QUINAPRIL tablet

Negara: Amerika Serikat

Bahasa: Inggris

Sumber: NLM (National Library of Medicine)

Beli Sekarang

Karakteristik produk Karakteristik produk (SPC)
01-01-2021

Bahan aktif:

QUINAPRIL HYDROCHLORIDE (UNII: 33067B3N2M) (QUINAPRILAT - UNII:34SSX5LDE5)

Tersedia dari:

Proficient Rx LP

INN (Nama Internasional):

QUINAPRIL HYDROCHLORIDE

Komposisi:

QUINAPRIL 10 mg

Rute administrasi :

ORAL

Jenis Resep:

PRESCRIPTION DRUG

Indikasi Terapi:

Hypertension Quinapril is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of

Ringkasan produk:

Quinapril tablets, USP are supplied as follows: 10-mg tablets : brown, round biconvex tablets de-bossed with IG on one side and 268 on other. NDC 63187-425-30 bottles of 30 tablets NDC 63187-425-60 bottles of 60 tablets NDC 63187-425-90 bottles of 90 tablets Dispense in well-closed containers as defined in the USP. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Protect from light. Manufactured by: InvaGen Pharmaceuticals, Inc Hauppauge, NY 11788 Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 Repackaged By: Proficient Rx LP Thousand Oaks, CA 91320 Rev: 05/15                                                      Barcode: 270-05-2015                                                                   

Status otorisasi:

Abbreviated New Drug Application

Karakteristik produk

                                QUINAPRIL- QUINAPRIL TABLET
PROFICIENT RX LP
----------
QUINAPRIL TABLETS, USP
RX ONLY
USE IN PREGNANCY
WHEN USED IN PREGNANCY DURING THE SECOND AND THIRD TRIMESTERS, ACE
INHIBITORS CAN CAUSE
INJURY AND EVEN DEATH TO THE DEVELOPING FETUS. When pregnancy is
detected, quinapril tablets
should be discontinued as soon as possible. See WARNINGS,
Fetal/Neonatal Morbidity and
Mortality.
DESCRIPTION
Quinapril hydrochloride USP is the hydrochloride salt of quinapril,
the ethyl ester of a non-sulfhydryl,
angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.
Quinapril hydrochloride USP is chemically described as [3S-[2[R*(R*)],
3R*]]-2-[2-
[[1(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1
,2,3,4-tetrahydro-3-isoquinolinecarboxylic
acid, monohydrochloride. Its empirical formula is C SH N S -HCl and
its structural formula is:
Quinapril hydrochloride USP is a white to off-white amorphous powder
that is freely soluble in
aqueous solvents.
Quinapril Tablets USP contain quinapril hydrochloride equivalent to 5
mg, 10 mg, 20 mg, or 40 mg of
quinapril for oral administration.
Each tablet also contains lactose monohydrate, magnesium carbonate,
magnesium stearate,
crospovidone, povidone and opadry brown (hypromellose, titanium
dioxide, iron oxide and macrogol).
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION:
Quinapril is deesterified to the principal metabolite, quinaprilat,
which is an inhibitor of ACE activity in
human subjects and animals. ACE is apeptidyl dipeptidase that
catalyzes the conversion of angiotensin I
to the vasoconstrictor, angiotensin II. The effect of quinapril in
hypertension appears to result primarily
from the inhibition of circulating and tissue ACE activity, thereby
reducing angiotensin II formation.
Quinapril inhibits the elevation in blood pressure caused by
intravenously administered angiotensin I,
but has no effect on the pressor response to angiotensin II,
norepinephrine or epinephrine. Angiotensin
II also stimulates the secretion of aldosterone from the adrenal
cortex, thereby facilitating renal s
                                
                                Baca dokumen lengkapnya
                                
                            

Peringatan pencarian terkait dengan produk ini